GALASSO, Gennaro
 Distribuzione geografica
Continente #
AS - Asia 14.615
NA - Nord America 10.423
EU - Europa 3.812
SA - Sud America 827
Continente sconosciuto - Info sul continente non disponibili 372
AF - Africa 158
OC - Oceania 10
Totale 30.217
Nazione #
US - Stati Uniti d'America 10.117
HK - Hong Kong 9.496
SG - Singapore 2.366
IT - Italia 1.585
CN - Cina 939
VN - Vietnam 850
BR - Brasile 586
RU - Federazione Russa 474
DE - Germania 409
UA - Ucraina 307
FR - Francia 220
IE - Irlanda 200
TR - Turchia 160
BD - Bangladesh 155
FI - Finlandia 153
CA - Canada 152
KR - Corea 145
IN - India 130
GB - Regno Unito 115
SE - Svezia 104
AR - Argentina 87
MX - Messico 79
JP - Giappone 66
ZA - Sudafrica 53
PL - Polonia 51
IQ - Iraq 49
ES - Italia 44
NL - Olanda 43
CO - Colombia 40
ID - Indonesia 34
EC - Ecuador 33
PK - Pakistan 29
SA - Arabia Saudita 27
MA - Marocco 24
PH - Filippine 24
CZ - Repubblica Ceca 23
VE - Venezuela 23
MY - Malesia 20
UZ - Uzbekistan 19
AT - Austria 18
KE - Kenya 17
PY - Paraguay 16
EU - Europa 14
AE - Emirati Arabi Uniti 13
EG - Egitto 13
JM - Giamaica 13
JO - Giordania 13
CL - Cile 12
KZ - Kazakistan 11
CR - Costa Rica 10
LT - Lituania 10
PE - Perù 9
DZ - Algeria 8
NP - Nepal 8
TN - Tunisia 8
UY - Uruguay 8
AZ - Azerbaigian 7
CH - Svizzera 7
IR - Iran 7
NI - Nicaragua 7
PA - Panama 7
AU - Australia 6
BH - Bahrain 6
ET - Etiopia 6
HN - Honduras 6
HU - Ungheria 6
IL - Israele 6
LB - Libano 6
LU - Lussemburgo 6
TT - Trinidad e Tobago 6
BE - Belgio 5
BO - Bolivia 5
GT - Guatemala 5
OM - Oman 5
PR - Porto Rico 5
SR - Suriname 5
AL - Albania 4
AO - Angola 4
PS - Palestinian Territory 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
BY - Bielorussia 3
GD - Grenada 3
HR - Croazia 3
KW - Kuwait 3
SC - Seychelles 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BS - Bahamas 2
CI - Costa d'Avorio 2
CY - Cipro 2
GA - Gabon 2
GE - Georgia 2
GF - Guiana Francese 2
GP - Guadalupe 2
LV - Lettonia 2
LY - Libia 2
MD - Moldavia 2
MN - Mongolia 2
Totale 29.816
Città #
Hong Kong 9.489
Ann Arbor 1.442
Singapore 1.212
San Jose 1.052
Chandler 683
Milan 616
Woodbridge 614
Ashburn 592
Dallas 575
Princeton 454
Jacksonville 440
Wilmington 411
Houston 366
Dong Ket 319
Council Bluffs 318
Beijing 285
Munich 224
Dublin 198
Lauterbourg 183
Ho Chi Minh City 182
New York 171
Los Angeles 155
Rome 155
The Dalles 155
Hanoi 132
Boardman 127
Izmir 118
Santa Clara 111
Moscow 102
Salerno 95
Andover 91
Turku 91
Nanjing 89
Memphis 77
Naples 72
São Paulo 70
Pellezzano 63
Tokyo 62
Figino 55
Columbus 53
Montreal 52
Denver 51
Fairfield 46
Warsaw 46
Turin 45
Frankfurt am Main 44
Chicago 41
Orem 40
Phoenix 39
Mestre 34
Seattle 34
Mexico City 33
Johannesburg 32
Brooklyn 31
Da Nang 30
Poplar 30
Nanchang 29
San Francisco 27
Atlanta 26
Changsha 26
Dearborn 25
Norwalk 25
Düsseldorf 24
Stockholm 24
Washington 24
Amsterdam 23
Shenyang 23
Chennai 22
Nuremberg 22
Baghdad 21
London 21
Fisciano 20
Manchester 20
Toronto 20
Falls Church 19
Jiaxing 19
Querétaro 19
Boston 18
Haiphong 18
Rio de Janeiro 18
Seoul 18
Buffalo 17
Brno 16
Tashkent 16
Ankara 15
Hebei 15
Nairobi 15
Belo Horizonte 14
Brasília 14
Florence 14
Mumbai 14
New Delhi 14
Charlotte 13
Redwood City 13
Amman 12
Bari 12
Guayaquil 12
Jeddah 12
Lahore 12
Porto Alegre 12
Totale 23.140
Nome #
No-Reflow Phenomenon: Pathophysiology, Diagnosis, Prevention, and Treatment. A Review of the Current Literature and Future Perspectives. 1.025
Clinical Characteristics and Outcomes of Patients With Takotsubo Syndrome and Left Ventricular Outflow Tract Obstruction 943
589 THE EFFECT OF DAPAGLIFLOZIN ON SYMPTOMS, QUALITY OF LIFE AND ECHOCARDIOGRAPHIC PARAMETERS IN A REAL-WORLD POPULATION OF HFREF PATIENTS 904
Abdominal Aortic Aneurysm: Natural History, Pathophysiology and Translational Perspectives 853
TRANSCATHETER IMPLANTABLE DEVICES TO MONITORING OF ELEVATED LEFT ATRIAL PRESSURES IN PATIENTS WITH CHRONIC HEART FAILURE 621
Plasma miR-1-3p levels predict severity in hospitalized COVID- 19 patients 584
Moving toward Precision Medicine in Acute Coronary Syndromes: A Multimodal Assessment of Non-Culprit Lesions 530
Artificial Intelligence in Hypertension Management: An Ace up Your Sleeve 477
Acute Coronary Syndrome in patients with SARS-CoV-2 infection: Pathophysiology and Translational Perspectives 461
Predictors of Recurrent Ischemic Events in Patients With ST-Segment Elevation Myocardial Infarction 437
An active lifestyle improves outcome of primary angioplasty in elderly patients with acute myocardial infarction. 432
[Diagnosis of cardiovascular involvement in Fabry disease] 414
Infective endocarditis and diabetes mellitus: Results from a single-center study from 1994 to 2017 391
Implantable cardioverter-defibrillator explosion after gunshot: When the device protects not only from arrhythmic death|Esplosione di defibrillatore impiantabile in seguito a colpo d’arma da fuoco: quando il defibrillatore non previene soltanto la morte aritmica 317
An innovative Olive Pâté with nutraceutical properties 304
1-Year Outcomes With Intracoronary Abciximab in Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention 299
Exercise training and cardiac rehabilitation in covid-19 patients with cardiovascular complications: State of art 299
COVID-19 and Acute Coronary Syndromes: From Pathophysiology to Clinical Perspectives 297
Bivalirudin in Patients Undergoing PCI: State of Art and Future Perspectives 294
Technological Developments, Exercise Training Programs, and Clinical Outcomes in Cardiac Telerehabilitation in the Last Ten Years: A Systematic Review 268
Long-term clinical outcomes following sirolimus-eluting stent implantation in patients with acute myocardial infarction. A meta-analysis of randomized trials 253
Importance of Echocardiography and Clinical "Red Flags" in Guiding Genetic Screening for Fabry Disease 249
The G-protein-coupled receptor kinase 5 inhibits NFkappaB transcriptional activity by inducing nuclear accumulation of IkappaB alpha. 248
Effects of physical activity on endothelial progenitor cells (EPCs) 237
Analysis of regional right ventricular function by tissue doppler imaging in patients with aortic stenosis 232
Unrestricted use of endeavor resolute zotarolimus-eluting stent in daily clinical practice: a prospective registry 217
An active lifestyle prior to coronary surgery is associated with improved survival in elderly patients. 205
Abciximab in elderly with acute coronary syndrome invasively treated: effect on outcome. 203
Clinical outcome of patients with ST-elevation myocardial infarction and angiographic evidence of coronary artery ectasia 192
Effect of an invasive strategy on outcome in patients ≥75 years of age with non-ST-elevation acute coronary syndrome 190
A new approach to percutaneous coronary revascularization in patients requiring undeferrable non-cardiac surgery. 187
Relationship between changes in platelet reactivity and ischemic events following percutaneous coronary intervention: a meta-regression analysis of 30 randomized trials 186
Whole-Exome Sequencing Revealed New Candidate Genes for Human Dilated Cardiomyopathy 182
Reperfusion correlates and clinical outcomes of right ventricular dysfunction in patients with inferior ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention 177
Twelve-month clinical outcomes of everolimus-eluting stent as compared to paclitaxel- and sirolimus-eluting stent in patients undergoing percutaneous coronary interventions. A meta-analysis of randomized clinical trials. 169
[Adipokines and coronary artery disease] 169
Adiponectin promotes endothelial progenitor cell number and function 168
Global longitudinal strain predicts outcome after MitraClip implantation for secondary mitral regurgitation 167
Polymer-free versus biodegradable-polymer drug-eluting stent in patients undergoing percutaneous coronary intervention: an assessor-blind, non-inferiority, randomised controlled trial 162
Clinical profile and in-hospital outcome of Caucasian patients with takotsubo syndrome and right ventricular involvement 162
Arterial Hypertension in Patients with Takotsubo Syndrome: Prevalence, Long-Term Outcome, and Secondary Preventive Strategies. A Report from the Takotsubo Italian Network Register 161
Nobori biolimus-eluting stent vs. permanent polymer drug-eluting stents in patients undergoing percutaneous coronary intervention 160
[Diabetes and ischemiccardiopathy] 158
Antiplatelet versus anticoagulation therapy after extracardiac conduit Fontan: a systematic review and meta-analysis. 156
Valve-in-Valve Transcatheter Aortic Valve Replacement: From Pre-Procedural Planning to Procedural Scenarios and Possible Complications 156
β2-Adrenergic receptor stimulation improves endothelial progenitor cell-mediated ischemic neoangiogenesis 154
Prior exercise improves age-dependent vascular endothelial growth factor downregulation and angiogenesis responses to hind-limb ischemia in old rats 152
Predictors of outcome in heart failure patients with severe functional mitral regurgitation undergoing MitraClip treatment 152
Pharmacotherapeutic considerations for the use of prasugrel and ticagrelor to reduce stent thrombosis in patients with acute coronary syndrome 150
[Is there an ideal stent for each type of coronarylesion?] 145
The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events. 143
Transradial versus transfemoral approach in patients undergoing percutaneous coronary intervention for acute coronary syndrome. A meta-analysis and trial sequential analysis of randomized controlled trials 142
Impaired angiogenesis in glutathione peroxidase-1-deficient mice is associated with endothelial progenitor cell dysfunction 141
Akt1/protein kinase Bα is critical for ischemic and VEGF-mediated angiogenesis 140
Adenosine-induced torsade de pointes complicating a fractional flow reserve measurement in a right coronary artery intermediate stenosis. 139
Long-term safety and efficacy of drug-eluting stents in patients with acute myocardial infarction: a meta-analysis of randomized trials. 138
In concomitant coronary and peripheral arterial disease,inflammation of the affected limbs predicts coronary artery endothelial dysfunction. 138
Role of beta2 adrenergic receptors in human atherosclerotic coronary arteries. 137
Angiogenic-regulatory network revealed by molecular profiling heart tissue following Akt1 induction in endothelial cells 137
Intracoronary abciximab in diabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 135
Benefits from new ADP antagonists as compared with clopidogrel in patients with stable angina or acute coronary syndrome undergoing invasive management: A meta-analysis of randomized trials 134
Pooled Analysis Comparing the Efficacy of Intracoronary Versus Intravenous Abciximab in Smokers Versus Nonsmokers Undergoing Primary Percutaneous Coronary Revascularization for Acute ST-Elevation Myocardial Infarction 132
Short-term Akt activation in cardiac muscle cells improves contractile function in failing hearts 132
Secondary Cardiovascular Prevention after Acute Coronary Syndrome: Emerging Risk Factors and Novel Therapeutic Targets 132
Safety and efficacy of non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation 131
Prognostic value of clinical, echocardiographic and angiographic indicators in patients with large anterior ST-segment elevation myocardial infarction as a first acute coronary event 130
Efficacy of automatic mode switching in DDDR mode pacemakers: The most 2 study 130
Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems 130
Effects of Ile164 polymorphism of beta2-adrenergic receptor gene on coronary artery disease. 129
Relationship between contractile reserve, Tl-201 uptake, and collateral angiographic circulation in collateral-dependentmyocardium: implications regarding the evaluation of myocardial viability. 129
Multicentre experience with MGuard net protective stent in ST-elevation myocardial infarction: safety, feasibility, and impact on myocardial reperfusion. 128
MGUard versus bAre-metal stents plus manual thRombectomy in ST-elevation myocarDial infarction pAtieNts-(GUARDIAN) trial: Study design and rationale. 127
Intravenous antiplatelet therapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 126
Precision and Personalized Medicine: How Genomic Approach Improves the Management of Cardiovascular and Neurodegenerative Disease 126
New perspectives for transcatheter aortic valve implantation: more than a "simple" alternative to surgery 124
A Multistep Approach to Deal With Advanced Heart Failure: A Case Report on the Positive Effect of Cardiac Contractility Modulation Therapy on Pulmonary Pressure Measured by CardioMEMS 123
Impact of diabetes on cardiac sympathetic innervation in patients with heart failure: A 123I meta-iodobenzylguanidine (123I MIBG) scintigraphic study 123
Glucose control with insulin results in reduction of NF-kappaB-binding activity in mononuclear blood cells of patients with recently manifested type 1 diabetes 123
Isolated Valve Amyloid Deposition in Aortic Stenosis: Potential Clinical and Pathophysiological Relevance 122
Everolimus- versus first generation drug-eluting stents: the never-ending story of searching for a winner in the "limus family". 121
Mortality reduction with transradial approach in patients with ST-segment elevation myocardial infarction: Is the randomized evidence conclusive? 121
Early stent thrombosis with bivalirudin in patients undergoing percutaneous coronary intervention: A meta-analysis of randomised clinical trials 121
Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction 121
Immediate and long-term outcome of recanalization of chronic total coronary occlusions. 120
Beta-blockers are associated with better long-term survival in patients with Takotsubo syndrome 119
Increased inflammatory status and higher prevalence ofthree-vessel coronary artery disease in patients with concomitant coronary andperipheral atherosclerosis. 118
Meta-analysis of randomized trials comparing the effectiveness of different strategies for the treatment of drug-eluting stent restenosis 118
In vivo properties of the proangiogenic peptide QK. 118
A novel promising frontier for human health: The beneficial effects of nutraceuticals in cardiovascular diseases 118
Rheolytic thrombectomy during percutaneous coronary interventionimproves long-term outcome in high-risk patients with acute myocardial infarction. 117
Coronary stenting early before non-cardiac surgery: is the endothelial progenitor cell capturing coronary stent a solution? 117
Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. 116
Impact of bivaluridin and Genous stent in patients with acute myeloid leukemia undergoing emergency percutaneous coronary angioplasty for acute coronary syndrome 116
Prognostic significance of the SYNTAX score and SYNTAX score II in patients with myocardial infarction treated with percutaneous coronary intervention 116
Clinical conditions and echocardiographic parameters associated with mortality in COVID-19 115
Exercise promotes angiogenesis and improves beta-adrenergic receptor signalling in the post-ischaemic failing rat heart. 115
Insulin-like growth factor-1 protects from vascular stenosis and accelerates re-endothelialization in a rat model of carotid artery injury 113
Vitamin D deficiency is independently associated with the extent of coronary artery disease 113
Bioabsorbable drug-eluting vascular scaffold for the treatment of coronary in-stent restenosis: A two center registry 112
Estimation of coronary flow reserve by Tc-99m sestamibi imaging in patients with coronary artery disease: comparison with the results of intracoronary Doppler technique 112
Totale 21.927
Categoria #
all - tutte 85.404
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.404


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022818 0 1 2 7 41 25 32 40 103 99 97 371
2022/20231.561 145 135 49 192 213 319 2 139 270 7 60 30
2023/2024809 99 114 52 28 54 104 19 38 5 36 32 228
2024/20252.549 61 33 41 117 90 232 429 136 357 160 483 410
2025/202618.735 3.391 3.878 3.469 730 1.545 591 1.576 342 652 1.130 377 1.054
2026/2027829 481 348 0 0 0 0 0 0 0 0 0 0
Totale 30.217